Oral delivery of macromolecules using intestinal patches: Applications for insulin delivery

Journal of Controlled Release

Volumn 98, Issue 1, 2004, Pages 37-45

  Whitehead, Kathryn ^a   Shen, Zancong ^a   Mitragotri, Samir ^a  

^a University of California   (United States)

Author keywords

Hypoglycemia; Insulin; Jejunum; Oral; Patch

Indexed keywords

ABSORPTION; BLOOD; DEGRADATION; DRUG PRODUCTS; GASTROENTEROLOGY; GLUCOSE; INSULIN; PROTEINS;

BLOOD GLUCOSE LEVELS; INSULIN ABSORPTION; MUCOADHESIVES;

MACROMOLECULES;

CARBOPOL 934; CARBOXYMETHYLCELLULOSE; GLUCOSE; INSULIN; METHYLCELLULOSE; PECTIN;

ARTICLE; DOSE RESPONSE; DRUG DELIVERY SYSTEM; GASTROINTESTINAL TRACT; GLUCOSE BLOOD LEVEL; HYPOGLYCEMIA; MACROMOLECULE; PRIORITY JOURNAL; PROTEIN DEGRADATION; SMALL INTESTINE ABSORPTION;

ADMINISTRATION, ORAL; ANIMALS; BLOOD GLUCOSE; CATTLE; DRUG DELIVERY SYSTEMS; INSULIN; INTESTINES; MACROMOLECULAR SUBSTANCES; MALE; RATS; RATS, SPRAGUE-DAWLEY; SWINE;

EID: 3042771832     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jconrel.2004.04.013     Document Type: Article

References (34)

1. Bernkop-Schnurch A., Walker G. Multifunctional matrices for oral peptide delivery. Crit. Rev. Ther. Drug Carr. Syst. 18:2001;459-501
2. Still J.G. Development of oral insulin. Diabetes/Metab. Res. Rev. 2002 (Jan.-Feb.);S29-S37
3. Fasano A., Uzzau S. Modulation of Intestinal tight junctions by zonula occludens toxin permits enteral administration of insulin and other macromolecules in an animal model. J. Clin. Invest. 99:1997;1158-1164
4. Uchiyama T., Sugiyama T., Quan Y., Kotani A., Okada N., Fujita T., Muranishi S., Yamamoto A. Enhanced permeability of insulin across the rat intestinal membrane by various absorption enhancers: their intestinal mucosal toxicity and absorption-enhancing mechanism of n-lauryl-beta-D-maltopyranoside. J. Pharm. Pharmacol. 51:1999;1241-1250
5. Yamamoto A., Okagawa T., Kotani A., Uchiyama T., Shimura T., Tabata S., Kondo S., Muranishi S. Effects of different absorption enhancers on the permeation of ebiratide, an ACTH analogue, across intestinal membranes. J. Pharm. Pharmacol. 49:1997;1057-1061
6. Yamamoto A., Taniguchi T., Rikyuu K., Tsuji T., Fujita T., Murakami M., Muranishi S. Effects of various protease inhibitors on the intestinal absorption and degradation of insulin in rats. Pharm. Res. 11:1994;1496-1500
7. Mathiowitz E., Jacob J.S., Jong Y.S., Carino G.P., Chickering D.E., Chaturvedi P., Santos C.A., Vijayaraghavan K., Montgomery S., Bassett M., Morrell C. Biologically erodable microspheres as potential oral drug delivery systems. Nature. 386:1997;410-414
8. Ma X., Pan G., Lu Z., Hu J., Bei J., Jia J., Wang S. Preliminary study of oral polylactide microcapsulated insulin in vitro and in vivo. Diabetes Obes. Metab. 2:2000;243-250
9. Lowman A., Morishita M., Kajita M., Nagai T., Peppas N. Oral delivery of insulin using pH-responsive complexation gels. J. Pharm. Sci. 88:1999;933-937
10. Ogiso T., Funahashi N., Tsukioka Y., Iwaki M., Tanino T. Oral delivery of synthetic eel calcitonin, elcatonin in rats. Biol. Pharm. Bull. 24:2001;656-661
11. Dogru S.T., Calis S., Oner F. Oral multiple w/o/w emulsion formulation of a peptide salmon calcitonin: in vitro-in vivo evaluation. J. Clin. Pharm. Ther. 25:2000;435-443
12. Iwanaga K., Ono S., Narioka K., Kakemi M., Morimoto K., Yamashita S., Namba Y., Oku N. Application of surface-coated liposomes for oral delivery of peptide: effects of coating the liposome's surface on the GI transit of insulin. J. Pharm. Sci. 88:1999;248-252
13. Kisel M., Kulik L., Tsybovsky I., Vlasov A., Vorob'yov M., Kholodova E., Zabarovskaya Z. Liposomes with phosphatidylethanol as a carrier for oral delivery of insulin: studies in the rat. Int. J. Pharm. 216:2001;105-114
14. Carino G.P., Mathiowitz E. Oral insulin delivery. Adv. Drug Deliv. Rev. 35:1999;249-257
15. Aungst B., Rogers N. Comparison of the effects of various transmucosal absorption promoters on buccal insulin delivery. Int. J. Pharm. 53:1989;227-235
16. Morishita M., Morishita I., Takayama K., Machida Y., Nagai T. Site-dependent effect of aprotinin, sodium caprate, Na2EDTA and sodium glycocholate on intestinal absorption of insulin. Biol. Pharm. Bull. 16:1993;68-72
17. Madsen F., Peppas N.A. Complexation graft copolymer networks: swelling properties, calcium binding and proteolytic enzyme inhibition. Biomaterials. 20:1999;1701-1708
18. Thanou M., Verhoef J.C., Junginger H.E. Oral drug absorption enhancement by chitosan and its derivatives. Adv. Drug Deliv. Rev. 52:2001;117-126
19. Lueßen H.L., Rentel C.-O., Kotze A.F., Lehr C.-M., de Bohr A.G., Verhoef J.C., Junginger H.E. Mucoadhesive polymers in peroral peptide drug delivery: IV. Polycarbophil and chitosan are potent enhancers of peptide transport across intestinal mucosae in vitro. J. Control. Release. 45:1997;15-23
20. Chung H., Kim J., Um J.Y., Kwon I.C., Jeong S.Y. Self-assembled "nanocubicle" as a carrier for peroral insulin delivery. Diabetologia. 45:2002;448-451
21. Carino G., Jacob J., Mathiowitz E. Nanosphere based oral insulin delivery. J. Control. Release. 65:2000;261-269
22. Milestein S.J., Leipold H., Sarubbi D., Leone-Bay A., Mlynek G.W., Robinson J.R., Kasimova M., Freire E. Partially unfolded proteins efficiently penetrate cell membranes - implications for oral drug delivery. J. Control. Release. 53:1998;259-267
23. Shen Z., Mitragotri S. Intestinal patches for oral drug delivery. Pharm. Res. 19:2002;391-395
24. Eiamtrakarn S., Itoh Y., Kishimoto J., Yoshikawa Y., Shibata N., Murakami M., Takada K. Gastrointestinal mucoadhesive patch system (GI-MAPS) for oral administration of G-CSF, a model protein. Biomaterials. 23:2002;145-152
25. Tao S.L., Lubeley M.W., Desai T.A. Bioadhesive poly(methyl methacrylate) microdevices for controlled drug delivery. J. Control Release. 88:2003;215-228
26. Bernkop-Schnürch A., Apprich I. Synthesis and evaluation of a modified mucoadhesive polymer protecting from alpha-chymotrypsinic degradation. Int. J. Pharm. 146:1997;247-254
27. Eiamtrakam S., Itoh Y., Kishimoto J., Yoshikawa Y., Shibata N., Murakami M., Takada K. Gastrointestinal mucoadhesive patch system (GI-MAPS) for oral administration of G-CSF, a model protein. Biomaterials. 23:2002;145-152
28. Thanou M., Verhoef J.C., Verheijden J.H., Juginger H.E. Intestinal absorption of octreotide using trimethyl chitosam chloride: studies in pigs. Pharm. Res. 18:2001;823-828
29. Michel C., Aprahamian M., Defontaine L., Couvreur P., Damge C. The effect of site of administration in the gastrointestinal tract on the absorption of insulin from nanocapsules in diabetic rats. J. Pharm. Pharmacol. 43:1991;1-5
30. Hosny E.A., Ghilzai N.M., Al-Dhawalie A.H. Effective intestinal absorption of insulin in diabetic rats using enteric coated capsules containing sodium aslicylate. Drug Dev. Ind. Pharm. 21:1995;1583-1589
31. Cole E.T., Scott R.A., Connor A.L., Wilding I.R., Petereit H.U., Schminke C., Beckert T., Cade D. Enteric coated HPMC capsules designed to achieve intestinal targetring. Int. J. Pharm. 231:2002;83-95
32. Bos J.D., Meinardi M.M. The 500 Dalton rule for the skin penetration of chemical compounds and drugs. Exp. Dermatol. 9:2000;165-169
33. Li C., Bhatt P.P., Johnston T.P. Evaluation of a mucoadhesive buccal patch for delivery of peptides: in vitro screening of bioadhesion. Drug Dev. Ind. Pharm. 24:1998;919-926
34. F.D.A., Inactive ingredient search for approved drug products, http://www.accessdata.fda.gov/scripts/cder/iig/index.cfm (2003)